SCHEMBL11279908

SCHEMBL11279908

CNC(=O)Nc1ccccn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.66
NPC1 O15118 8/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
ADORA3 P0DMS8 1/20 0.66
PIM1 P11309 1/20 0.66
ADORA2A P29274 1/20 0.66
ADORA2B P29275 1/20 0.66
ADORA1 P30542 1/20 0.66
FLT3 P36888 1/20 0.66
PIM3 Q86V86 1/20 0.66
AURKB Q96GD4 1/20 0.66
PKM P14618 2/20 0.66
LMNA P02545 1/20 0.62
GAA P10253 1/20 0.61
HTT P42858 1/20 0.59
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
MAPT P10636 1/20 0.58
TSHR P16473 1/20 0.57
GCK P35557 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9750118 0.88 NPC1 (0.81) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL10856293 0.83 RAB9A (0.59) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL10755570 0.83 RAB9A (0.54) RAB9ANPC1SMN1; SMN2ADORA3PIM1
Hydrochloric Acid SCHEMBL11053107 0.82 RAB9A (0.57) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL29940946 0.81 RAB9A (0.62) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL8665367 0.81 RAB9A (0.66) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL18469876 0.81 RAB9A (0.66) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL12376730 0.80 RAB9A (0.60) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL12410301 0.80 SMN1; SMN2 (0.72) RAB9ANPC1SMN1; SMN2ADORA3PIM1
SCHEMBL12376732 0.80 RAB9A (0.60) RAB9ANPC1SMN1; SMN2ADORA3PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351522-B2 Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof UNIVERSITY OF TSUKUBA (JP) 2019-07-16 US disclosed
US-20180179151-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF UNIVERSITY OF TSUKUBA (JP) 2018-06-28 US disclosed
WO-2017023894-A1 MTHFD2 INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-02-09 WO disclosed
US-8865837-B2 Organosilicon compounds, production processes thereof, pressure-sensitive adhesive compositions containing the organosilicon compounds, self-adhesive polarizers and liquid crystal displays SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-10-21 US disclosed
US-8450417-B2 Organosilicon compounds, production processes thereof, pressure-sensitive adhesive compositions containing the organosilicon compounds, self-adhesive polarizers and liquid crystal displays SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-05-28 US disclosed
US-8431649-B2 Organosilicon compounds, production processes thereof, pressure-sensitive adhesive compositions containing the organosilicon compounds, self-adhesive polarizers and liquid crystal displays SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-04-30 US disclosed
US-20130066014-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-03-14 US disclosed
US-20130053515-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-02-28 US disclosed
US-20120322946-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-12-20 US disclosed
US-8003662-B2 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. (US) 2011-08-23 US disclosed
US-20110039893-A1 GSK-3BETA INHIBITOR TAKEDA PHARMACEUTICAL COMPANY LIMITED 2011-02-17 US disclosed
US-20100060829-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-03-11 US disclosed
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. 2007-08-23 US disclosed
CN-1906167-A Novel pyridine derivative and pyrimidine derivative (2) EISAI CO LTD (JP) 2007-01-31 CN disclosed
CN-1906166-A Novel pyridine derivative and pyrimidine derivative (1) EISAI CO LTD (JP) 2007-01-31 CN disclosed
US-4334912-A HERBICIDES WHICH ARE NONPHYTOTOXIC TO CROPS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322946-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS L1CAM, CDH1, CCND1 RAB9A 629/4885NPC1 2725/4885SMN1; SMN2 3027/4885
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ERBB2, LCK, SRC RAB9A 2056/4885NPC1 1260/4885SMN1; SMN2 2264/4885
US-20180179151-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF HCRTR2, HCRTR1, NPSR1 RAB9A 2688/4885NPC1 733/4885SMN1; SMN2 1062/4885
US-20110039893-A1 GSK-3BETA INHIBITOR GSK3B, GSK3A, GSKIP RAB9A 2254/4885NPC1 1656/4885SMN1; SMN2 865/4885
US-20130066014-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS L1CAM, CDH1, CCND1 RAB9A 629/4885NPC1 2725/4885SMN1; SMN2 3027/4885
US-20130053515-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS L1CAM, CDH1, CCND1 RAB9A 629/4885NPC1 2725/4885SMN1; SMN2 3027/4885
US-10351522-B2 Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof HCRTR2, HCRTR1, NPSR1 RAB9A 2688/4885NPC1 733/4885SMN1; SMN2 1062/4885
US-20100060829-A1 ORGANOSILICON COMPOUNDS, PRODUCTION PROCESSES THEREOF, PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS CONTAINING THE ORGANOSILICON COMPOUNDS, SELF-ADHESIVE POLARIZERS AND LIQUID CRYSTAL DISPLAYS L1CAM, CDH1, CCND1 RAB9A 629/4885NPC1 2725/4885SMN1; SMN2 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.